A Cost-Effectiveness Analysis of Cisplatin Plus Pemetrexed Doublet Induction Treatment Followed by Pemetrexed Maintenance Compared with Bevacizumab Plus Cisplatin Plus Gemcitabine Triplet Induction Treatment Followed by Bevacizumab Maintena ...
Abstract
Authors
P.A. Bryden G. Kumar K.B. Winfree M.E. Boye K. Taipale R. Thompson H. Borgeke